The Evidilya Company Profile: the variable that decides a study, reaching the right participants and keeping them engaged to the last visit.
We exist to make those provable – with evidence drawn from real lives, including the lives research usually leaves out, and held to a standard regulators, clinicians and payers can act on.
Research that runs continuously, reaches everyone it should, and turns what happens in real life into proof health systems can act on – right when they need it.
Centralised, hybrid or fully decentralised – the model follows the evidence you need. We run the whole arc, from the evidence question to the published result, in one digital ecosystem, with our team from start to finish.
When the two pull against each other, the person comes first – every design decision, from where a study happens to what we ask of a participant, is made in that order.
Read the full profile in the browser: use the arrows, the thumbnails, or swipe. The download stays one click away.
Each chapter of the profile maps to a part of the business you can go deeper on.
Ask a sponsor what made the difference on a study that delivered, and the answer is almost always reach: the right participants found early, enrolled fast and kept engaged. The right participants live everywhere – dispersed, sometimes rare, often far from a specialist centre. We built a CRO around that reality, so the science gets the population it deserves.
The reach thesis →ECS®, the Evidence Capture System, is Evidilya's virtual research ecosystem: five layers — Engage, Conduct, Capture, Operate, Assure — running a study end to end, from fully remote to hybrid, under a single governance model. Where an assembled vendor stack hands context from one supplier to the next, ECS® keeps it – so every data point carries its provenance and every hour goes into the study.
Explore ECS® →D-T-P is our default execution model: investigator-supervised, audited exactly like a site visit. Remote enrolment and identity-verified eConsent, at-home sampling with cold chain, ePRO on the device people already own, telehealth under supervision, and community pharmacies as physical touchpoints.
How D-T-P runs →AIRA is where insight becomes evidence: literature triage, protocol drafting and signal detection accelerated so scientists spend their hours on judgement. Every model is auditable, every output traceable, and a named human signs the scientific conclusion. Health Scientific Survey sits inside AIRA as a distinct capability.
AI Applied →Participants, the clinicians who see them and the researchers who turn what happens into evidence are designed for in the same protocol: fewer avoidable visits, clearer consent, less administrative load on the site, and a plan the sponsor can hold to. When the two pull against each other, the person comes first.
Who is Evidilya →Senior by default. Your study is scoped, staffed and overseen by named, experienced specialists, and the people accountable for it stay accountable for it. One accountable team follows the study across initiation, conduct and closing, covering the full arc of research, from evidence strategy, protocol development and regulatory strategy, through recruitment, monitoring and pharmacovigilance, to biostatistics, medical writing and peer-reviewed publication.
Expert Services →ICH E6(R3) and its Annex 2, the FDA final guidance of 18 September 2024 on trials with decentralised elements, and the EMA/HMA/European Commission recommendation paper of December 2022 all describe the way we already run studies. On top of that frame we make one written commitment: a configuration proposal within 60 days of a protocol synopsis.
Quality & governance →The scientific standard and the reach stay constant; the operating model flexes to what each study requires. Therapeutic experience is organised into ten clusters, grouped the way care actually happens.
Post-market and real-world evidence that reaches patients wherever they live, including rare populations far from a specialist centre.
Explore the domain →Claim substantiation at market speed, generated in real life, in the conditions your consumers actually use the product.
Explore the domain →From FSMP and infant nutrition to botanicals and novel food, with endpoints regulators and retailers both accept.
Explore the domain →MDR/IVDR investigations pre-market, and continuous PMCF evidence once the device is in use.
Explore the domain →Full-service is the frame; FSP and consultative advisory are modalities inside it. Whichever way you come in, one Expert team owns the outcome.
Evidilya runs the study end-to-end on ECS®, from protocol to publication. One accountable partner.
You keep your systems and your sites; our expert specialists run the study, or embed inside your team (FSP) for named functions, or advise as a defined consultative engagement.
Your team runs the study; ECS® is the validated, supported virtual research ecosystem underneath. No full-service required.
When reach decides whether your protocol becomes evidence, this is the conversation we are built for. Send the synopsis, or just the question.
